Cholinergic enhancement increases the effects of voluntary attention but does not affect involuntary attention.
Voluntary visual spatial attention can be allocated in a goal-oriented manner to locations containing behaviorally relevant information. In contrast, involuntary attention is automatically captured by salient events. Allocation of attention is known to be modulated by release of the neurotransmitter acetylcholine (ACh) in cerebral cortex. We used an anti-predictive spatial cueing task to assess the effects of pharmacological enhancement of cholinergic transmission on behavioral measures of voluntary and involuntary attention in healthy human participants. Each trial began with the presentation of a cue in a peripheral location. In 80% of the trials, a target then appeared in a location opposite the cue. In the remaining 20% of trials, the target appeared in the cue location. For trials with short stimulus onset asynchrony (SOA) between cue and target, involuntary capture of attention resulted in shorter reaction times (RTs) to targets presented at the cue location. For long SOA trials, allocation of voluntary attention resulted in the opposite pattern: RTs were shorter when the target appeared in the expected (opposite) location. Each subject participated in two sessions: one in which the cholinesterase inhibitor donepezil was administered to increase synaptic ACh levels and one in which placebo was administered. Donepezil selectively improved performance (reduced RT) for long SOA trials in which targets appeared in the expected location. Thus, cholinergic enhancement augments the benefits of voluntary attention but does not affect involuntary attention, suggesting that they rely on different neurochemical mechanisms.
Rokem
Ariel
A
Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720-2020, USA. arokem@berkeley.edu
Landau
Ayelet N
AN
Garg
Dave
D
Prinzmetal
William
W
Silver
Michael A
MA
D000328:Adult; D001288:Attention / Q000187:drug effects / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003463:Cues; D000077265:Donepezil; D005260:Female; D006801:Humans; D007189:Indans / Q000494:pharmacology; D008297:Male; D010880:Piperidines / Q000494:pharmacology; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D013037:Spatial Behavior / Q000187:drug effects / Q000502:physiology*
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil
Eur J Pharmacol. 1999 Dec 10;386(1):7-13
10611458
Psychon Bull Rev. 1994 Dec;1(4):476-90
24203555
Lancet. 2004 Jun 26;363(9427):2105-15
15220031
Trends Cogn Sci. 2006 Jan;10(1):38-45
16318922
Eur J Neurosci. 1999 Oct;11(10):3597-609
10564367
J Neurosci. 1994 Apr;14(4):2313-26
7512637
Spat Vis. 1997;10(4):437-42
9176953
PLoS Med. 2007 Nov 27;4(11):e338
18044984
Eur J Neurosci. 2006 Jul;24(1):314-28
16882027
Spat Vis. 1997;10(4):433-6
9176952
Neuropsychologia. 2008 Mar 7;46(4):1032-40
18166203
Q J Exp Psychol (Hove). 2009 Feb;62(2):352-69
18609402
Percept Psychophys. 1990 Sep;48(3):243-51
2216651
Neurology. 2001 Aug 14;57(3):481-8
11502917
J Neurosci. 2007 Oct 31;27(44):11986-90
17978039
Neuron. 2008 Dec 10;60(5):904-14
19081383
Drugs Aging. 2004;21(1):43-53
14715043
J Exp Psychol Gen. 2005 Feb;134(1):73-92
15702964
Neuroscience. 2006 Feb;137(3):853-64
16309846
J Neurophysiol. 1987 Oct;58(4):765-80
3681394
Schizophr Res. 1996 May;20(1-2):33-50
8794492
Brain Res Brain Res Rev. 2005 Feb;48(1):98-111
15708630
Neuropsychopharmacology. 2008 Mar;33(4):731-8
17551539
J Neurosci. 2005 May 4;25(18):4593-604
15872107
J Exp Psychol. 1980 Jun;109(2):160-74
7381367
Br J Clin Pharmacol. 1998 Nov;46 Suppl 1:1-6
9839758
Nature. 2008 Aug 28;454(7208):1110-4
18633352
Mol Neurobiol. 2007 Oct;36(2):184-200
17952661
Nicotine Tob Res. 2002 May;4(2):185-94
12028851
Neuroscience. 2006 Aug 11;141(1):201-12
16713104
Neuron. 2004 Mar 25;41(6):969-82
15046728
J Neurophysiol. 2007 Jan;97(1):229-37
16971677
Percept Psychophys. 1980 Sep;28(3):241-8
7433002
J Exp Psychol Hum Percept Perform. 1990 Feb;16(1):121-34
2137514
Philos Trans R Soc Lond B Biol Sci. 1982 Jun 25;298(1089):187-98
6125970
Brain Res. 1983 Dec 19;289(1-2):143-55
6661640
J Neurophysiol. 2005 Apr;93(4):2062-72
15548624
Neuroscience. 2002;114(2):451-60
12204214
Neuron. 2007 Oct 4;56(1):141-54
17920021